Search results for "Irritable bowel syndrome"
New best practice advice tackles pain in disorders of gut-brain interaction
An expert review from the American Gastroenterological Association cautioned against using opioids to treat pain from irritable bowel syndrome, functional dyspepsia, or centrally mediated abdominal pain syndrome, among other advice.
https://gastroenterology.acponline.org/archives/2021/07/23/2.htm
23 Jul 2021
Spotlight on COVID-19's impact on gastroenterology
Speakers at Digestive Disease Week shared research on how the COVID-19 pandemic has affected health care utilization, telehealth, and outcomes for patients with GI cancers.
https://gastroenterology.acponline.org/archives/2021/05/28/6.htm
28 May 2021
Spotlight on functional GI disorders
Research in the past month focused on irritable bowel syndrome (IBS) and functional dyspepsia, finding a worse disease prognosis among patients with both conditions versus IBS alone, as well as sex-based differences and an inverse association between fruit intake and functional dyspepsia symptoms.
https://gastroenterology.acponline.org/archives/2021/04/23/5.htm
23 Apr 2021
MKSAP Quiz: Treatment of diarrhea and abdominal pain
This month's quiz asks readers to determine the most appropriate treatment for a 35-year-old man with a one-year history of diarrhea and abdominal cramping and bloating.
https://gastroenterology.acponline.org/archives/2020/11/20/4.htm
20 Nov 2020
Use of drugs, nondrug treatments for functional bowel disorders analyzed
One study found that nonpharmacologic interventions are underused in ambulatory care visits for functional bowel disorders, while another found that patients with irritable bowel disease and their insurers have financial incentives to favor differing treatments.
https://gastroenterology.acponline.org/archives/2020/10/23/1.htm
23 Oct 2020
New guidelines support probiotics for C. difficile prevention, but few other uses
The American Gastroenterological Association recommended that probiotics be used to treat patients with Clostridioides difficile infection, Crohn's disease, ulcerative colitis, or irritable bowel syndrome only in the context of a clinical trial.
https://gastroenterology.acponline.org/archives/2020/06/26/1.htm
26 Jun 2020
In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months
While fecal microbiota transplantation was effective in patients with moderate to severe irritable bowel syndrome in a randomized trial, long-term risks of the therapy remain uncertain, an ACP Journal Club commentary noted.
https://gastroenterology.acponline.org/archives/2020/05/22/10.htm
22 May 2020
Spotlight on IBS treatments
In the past month, several studies looked at potential treatments for irritable bowel syndrome (IBS), including a probiotic strain, psychological therapies, and internet-based versus face-to-face education.
https://gastroenterology.acponline.org/archives/2020/04/24/5.htm
24 Apr 2020
Treatments for irritable bowel syndrome examined
A network meta-analysis looked at trials comparing soluble fiber, antispasmodic drugs, peppermint oil, and gut-brain neuromodulators with each other or with placebo, while a randomized controlled trial tested fecal microbiota transplantation.
https://gastroenterology.acponline.org/archives/2019/12/27/1.htm
27 Dec 2019
Two-year results show continued benefit of phone or web CBT for refractory IBS
Patients with irritable bowel syndrome (IBS) who had been randomized to receive remote cognitive behavioral therapy (CBT) had lower symptom severity scores than those who had received usual care, according to follow-up data from a British trial.
https://gastroenterology.acponline.org/archives/2019/09/27/3.htm
27 Sep 2019